FinalDose

FinalDose develops programmable DNA therapeutics that eliminate diseased cells by targeting pathogenic genetic sequences.

Latest funding

Latest round on record: Pre Seed, June 2026, amount undisclosed.

Website: finaldose.ai.

X: @FinalDoseLFG · 38 followers.

LinkedIn: finaldose.

Category: Health and bio.

Sectors: Healthcare, Therapeutics, Artificial Intelligence, Gene Therapy, Genetic Engineering.

Stage: Pre Seed.

Based in: Oxford, United Kingdom.

Last round: Jun 16, 2026 · 149 days ago.

Team: 5 people on the team page.

On Recent Funding since: Sep 28, 2026.

Signals

X account@FinalDoseLFG · created Oct 28, 2025 (13 months old) · 38 followers

Website registeredOct 20, 2025 (13 months old)

TIMELINE · MILESTONES

@FinalDoseLFG·1 round·2 signals before the first raise

One step per dated milestone. Pins are dated signals; hover the icons for dates.

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/finaldose (get a free API key).